Figure 2.
Forest plots of XRCC1 mutant type homozygote and heterozygote versus wild type homozygote on overall survival in ovarian cancer patients who received platinum-based chemotherapy. (A) 194TrpTrp versus 194ArgArg. (B) 194TrpArg versus 194ArgArg. (C) 280HisHis versus 280ArgArg. (D) 280HisArg versus 280ArgArg. (E) 399GlnGln versus 399ArgArg. (F) 399GlnArg versus 399ArgArg.